Park Medi World IPO GMP: Day 1 IPO Live Updates

The Park Medi World IPO GMP is ₹26 as of 10th December 2025. It is a bookbuilding IPO of ₹920.00 crores. This is an entirely fresh issue of 4.75 crore shares, and an offer for sale of 0.93 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 17th December 2025. The face value of  Park Medi World IPO shares is ₹2 per share, and the IPO price band is ₹154 to ₹162 per share. Retail investors can bid for a minimum of 1 lot of 92 shares worth ₹14,904

Park Medi World IPO GMP Grey Market Premium

As mentioned earlier, the Park Medi World IPO GMP currently stands at ₹26 per share. Thus, the estimated listing price would be flat at ₹188.00. This indicates that the estimated listing gain in this IPO could be 16.05%. Explore the table for Riddhi Display Equipment IPO GMP updates.

Note: GMP details are subject to change based on market conditions and fluctuations. Check live Park Medi World IPO GMP status at Univest.

Park Medi World IPO Details

Also Read: Park Medi World  IPO GMP & Review: Apply or Avoid?

Explanation

Park Medi World IPO: Park Medi World IPO Limited has declared an issue price band of ₹154 to ₹162 per share. With this IPO, the company allows retail investors to bid for at least one lot of 92 shares, each worth ₹14,904. The face value of Park Medi World IPO Limited shares is ₹2 per share. The shares of Park Medi World IPO Limited will be listed on BSE and NSE on its tentative listing day, 17th December 2025. Scroll down to check GMP updates and Park Medi World IPO reviews. 

Park Medi World IPO Objectives

The primary aim of the Park Medi World IPO is to raise ₹920 crores. On the other hand, Park Medi World has decided to utilise these funds in different ways.

• To Repayment/ prepayment, in whole or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries.
• To fund capital expenditure for the development of a new hospital and the expansion of the existing hospital by our certain Subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively.
• To fund capital expenditure for the purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri.
• To Unidentified inorganic acquisitions and general corporate purposes.

Park Medi World IPO Registrar

Kfin Technologies Limited is the registrar for the Park Medi World IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Park Medi World allotment and refund, you can contact Kfin Technologies Limited at parkmedi.ipo@kfintech.com  or at 0406716222 or 04079611000.

Park Medi World IPO Review

The Park Medi World IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Park Medi World Limited’s revenue increased by 13% from ₹1,263.08 crores in March 2024  to ₹1,425.97 crores in March 2025. Moreover, the company’s PAT increased by 40% from ₹152.01 crores in March 2024 to ₹213.22 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Park Medi World IPO or not.

Park Medi World IPO Technicals

The PE ratio of Park Medi World Limited shares is 29.21, and its Earnings Per Share (EPS) stands at 5.55. Thus, the Park Medi World IPO can deliver gains on its tentative listing date, 17th December 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Park Medi World  Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

FAQs on Park Medi World IPO

What is the Park Medi World IPO GMP?

Currently, on 10th December 2025, the Park Medi World IPO GMP (Grey Market Premium) stands at ₹26. This indicates that the estimated listing price could be ₹188 per share.

What is the issue price of Park Medi World IPO?

The Park Medi World IPO issue price band is set at ₹154.00 to ₹162.00 per share. Retail investors can apply for a minimum of 1 lot, each consisting of 92 shares, worth ₹14,904. Moreover, HNIs are required to bid for a minimum of 14 lots (1,288 shares) worth ₹2,08,656.

Who is the registrar of the Park Medi World IPO?

Kfin Technologies Limited is the registrar for the Park Medi World IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Park Medi World allotment and refund, you can contact Kfin Technologies Limited at parkmedi.ipo@kfintech.com  or 04067162222, 04079611000.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Park Medi World IPO, download the Park Medi World IPO RHP and Park Medi World IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Ravelcare IPO GMP: Day 3 IPO Live Updates

Astron Multigrain IPO Subscription Day 2

Astron Multigrain IPO GMP: Day 2 IPO Live Updates

Invicta Diagnostic IPO Subscription Day 2

Invicta Diagnostic IPO GMP: Day 2 IPO Live Updates

Park Medi World  IPO GMP & Review: Apply or Avoid?